Concise answers when you need the essentials, with deeper clinical context and transparent source links when the decision needs more scrutiny.
Search by active ingredient or familiar medicine name.
An intravenous amino-acid solution used as the protein component of parenteral nutrition for babies and children when feeding by mouth or through the gut is impossible, inadequate or unsuitable. It is normally combined with energy and other required nutrients.
This is a three-compartment parenteral nutrition infusion containing amino acids, glucose and fats. It provides protein-building material and energy directly into the bloodstream when nutrition by mouth or through the gut is impossible, insufficient or contraindicated.
A parenteral nutrition emulsion containing amino acids, glucose and fats. It supplies protein-building components and energy directly into the bloodstream when nutrition by mouth or through the gut is impossible, insufficient or contraindicated.
This is a three-chamber parenteral nutrition infusion containing amino acids, glucose and lipids, including essential fatty acids. It supplies energy, protein-building components and fluid when oral or tube feeding is impossible, inadequate or contraindicated; electrolytes and micronutrients must be prescribed separately as needed.
This is a two-chamber parenteral nutrition infusion containing amino acids, glucose, electrolytes and fluid. It supports adults and children aged 2 to 17 years with moderate to severe catabolism when nutrition through the mouth or gut is impossible, insufficient or contraindicated. Other nutritional components, including lipid, vitamins and trace elements, may still be required.
This is a parenteral nutrition solution containing amino acids, glucose, electrolytes and fluid. It is infused into the bloodstream when nutrition by mouth or through the gut is impossible, insufficient or contraindicated.
A sterile parenteral nutrition solution containing amino acids, glucose, electrolytes and fluid. It is used when nutrition by mouth or through the gut is impossible, insufficient or contraindicated in people with mild to moderate catabolism. Lipids, essential fatty acids, vitamins and trace elements may need to be supplied separately.
A three-compartment parenteral nutrition preparation containing amino acids, glucose, fats and electrolytes. It supplies nutrition directly into the bloodstream when feeding by mouth or through the gut is impossible, insufficient or unsuitable.
This is a three-part parenteral nutrition emulsion containing amino acids, glucose, fats and electrolytes. It provides nutrition directly into the bloodstream when feeding by mouth or through the gut is impossible, insufficient or unsuitable.
A combined parenteral nutrition product for preterm newborns. It supplies amino acids, glucose, electrolytes and, when needed, fats directly into the bloodstream when milk or other enteral feeding is unsuitable or insufficient.
A three-chamber parenteral nutrition emulsion containing amino acids, glucose, fats, electrolytes and fluid. It provides nutrition directly into the bloodstream when nutrition by mouth or through the gut is impossible, inadequate or unsuitable.
This is a three-chamber intravenous nutrition product containing amino acids, glucose, electrolytes and an optional lipid emulsion. It is used when a child or adolescent cannot receive enough nutrition by mouth or through the gut.
This is a three-chamber parenteral nutrition infusion containing amino acids, glucose, fats, electrolytes and fluid. It supports nutrition when food cannot be taken or absorbed adequately through the gut.
A parenteral nutrition solution containing amino acids, glucose and electrolytes. It provides nutrition directly into the bloodstream when feeding by mouth or through the gut is impossible, inadequate or contraindicated. Lipids, vitamins and trace elements may need to be added according to individual requirements.
This is a glucose-free amino acid and electrolyte solution used inside the abdomen for peritoneal dialysis. It removes fluid and waste across the peritoneal membrane while supplying absorbable amino acids, particularly for people with chronic kidney failure who are malnourished.
This is a three-chamber parenteral nutrition infusion containing amino acids, glucose, fats and electrolytes. It is used in adults who cannot obtain enough nutrition by mouth or through a feeding tube.
This is a sterile intravenous mixture of amino acids, the building blocks used to make proteins. It is used as part of parenteral nutrition when adequate nutrition cannot be absorbed by mouth or through the gut, alongside suitable energy and other required nutrients.
Albutrepenonacog alfa is a recombinant clotting factor IX joined to albumin so it remains active in the circulation for longer. It replaces missing factor IX to prevent or control bleeding in people with haemophilia B.
Alclometasone dipropionate is a moderately potent corticosteroid applied to the skin. It reduces inflammation and itching in corticosteroid-responsive skin conditions such as eczema and dermatitis.
Alectinib hydrochloride is a targeted cancer treatment called an ALK tyrosine kinase inhibitor. It is used for adults with ALK-positive non-small-cell lung cancer, including after complete tumour removal and in advanced disease.
Alemtuzumab is a monoclonal antibody that targets CD52-bearing lymphocytes. It is licensed for defined adults with highly active relapsing-remitting multiple sclerosis and is given under specialist hospital supervision.
Alendronate sodium trihydrate provides alendronic acid, a bisphosphonate that slows bone breakdown. Selected products are licensed to treat postmenopausal osteoporosis and reduce spine and hip fracture risk.
This prescription tablet combines alendronate, which slows bone breakdown, with colecalciferol (vitamin D3), which supports calcium absorption and normal bone formation. It is licensed for postmenopausal osteoporosis in women at risk of vitamin D insufficiency and reduces vertebral and hip fracture risk.
Alfacalcidol is a vitamin D analogue that the liver rapidly converts into active vitamin D. It helps regulate calcium and phosphate and is mainly used when vitamin D activation or calcium metabolism is impaired, including in kidney and parathyroid disorders.
Alfentanil hydrochloride is a potent, fast-acting opioid analgesic given intravenously. It is mainly used by anaesthetic teams to prevent or control pain during general anaesthesia and surgical procedures.
Alfuzosin hydrochloride is an alpha-blocker used mainly for urinary symptoms caused by a non-cancerous enlarged prostate. It relaxes muscle around the prostate and bladder outlet, helping urine flow more easily; it does not shrink the prostate.
Alglucosidase alfa is a recombinant form of the acid alpha-glucosidase enzyme deficient in Pompe disease. It is used as long-term enzyme replacement therapy to reduce glycogen accumulation and support muscle, breathing and heart function.
Alimemazine tartrate is a sedating phenothiazine antihistamine. Selected products are licensed for urticaria and itching, and for pre-anaesthetic sedation in young children; age and formulation restrictions vary by product.
Alirocumab is an injectable monoclonal antibody that lowers LDL cholesterol by blocking PCSK9. It is used when cholesterol remains high despite other treatment, when statins cannot be used, and to reduce cardiovascular risk in adults with established atherosclerotic disease.
Alitretinoin is an oral retinoid related to vitamin A, licensed for adults with severe chronic hand eczema that has not responded to potent topical corticosteroids.
This combination is a local haemorrhoid treatment. Lidocaine numbs the affected area to relieve pain and irritation, while allantoin is included to support healing. The ointment is licensed for external haemorrhoids and the suppositories for rectal use.
Allopurinol is a xanthine-oxidase inhibitor that lowers uric acid production. It helps prevent gout and certain kidney stones and reduces harmful uric acid accumulation in some high-cell-turnover conditions.
Almotriptan is a triptan used to relieve the headache phase of a migraine attack, with or without aura. It treats an attack after it starts and does not prevent future migraines.
Alogliptin benzoate provides alogliptin, a DPP-4 inhibitor that helps lower blood glucose. It is licensed for adults with type 2 diabetes alongside other glucose-lowering treatments when diet, exercise and existing treatment have not provided adequate control.
This fixed-combination tablet contains alogliptin, a DPP-4 inhibitor, and metformin, a biguanide. It is licensed for adults with type 2 diabetes when metformin alone is insufficient, when both ingredients are already used, or in certain combinations with insulin or pioglitazone.
Alpelisib is an oral targeted anticancer treatment that blocks PI3K-alpha. In the UK, it is licensed with fulvestrant for certain PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast cancers that have progressed after endocrine-based therapy.
Alprazolam is a benzodiazepine that enhances inhibitory GABA signalling in the brain. The selected UK product is licensed for short-term symptomatic treatment of severe, disabling or extremely distressing anxiety in adults.
Alprostadil is a form of prostaglandin E1 that relaxes smooth muscle and widens blood vessels. It is used for erectile dysfunction in adults and, as a specialist hospital infusion, to temporarily keep the ductus arteriosus open in babies with certain congenital heart defects.
Alteplase is a thrombolytic treatment that dissolves fibrin-rich blood clots. In hospital, it is used for selected patients with acute ischaemic stroke, heart attack or a large pulmonary embolism causing circulatory instability.
Aluminium chloride hexahydrate is a strong topical antiperspirant used to manage excessive sweating. The selected UK product is licensed for hyperhidrosis affecting the armpits, hands or feet.
This combination contains two antacids that neutralise stomach acid and simeticone, an anti-foaming agent that helps gas bubbles join together and pass more easily. Selected UK products are used for temporary relief of indigestion, heartburn, excess acidity and wind.
This combination is an antacid that neutralises acid already present in the stomach. It provides temporary relief of heartburn, acid indigestion, reflux-related dyspepsia and other licensed acid-related symptoms, but does not treat their underlying cause.
Alverine citrate is an antispasmodic that acts directly on smooth muscle. It is used to relieve cramping pain associated with irritable bowel syndrome, painful diverticular disease and primary period pain.
Alverine citrate + simeticone combines an antispasmodic with an antiflatulent. It is used in adults to relieve abdominal pain associated with irritable bowel syndrome, while reducing gut spasm and gas bubbles.
Amantadine hydrochloride is an antiparkinsonian treatment that alters signalling involved in movement control. Selected products are licensed for Parkinson’s disease; certain capsules and syrup are also licensed for influenza A and shingles-related pain. It is not recommended for seasonal influenza because resistance is widespread.
Ambrisentan is an endothelin receptor antagonist used for pulmonary arterial hypertension (PAH). It widens pulmonary arteries, reducing resistance to blood flow and the workload on the heart.
Amifampridine phosphate is a potassium-channel blocker that increases acetylcholine release from nerve endings. The selected product is licensed for symptomatic treatment of Lambert-Eaton myasthenic syndrome in adults, improving nerve-to-muscle signalling rather than treating the underlying cause.
Amikacin sulfate is an aminoglycoside antibiotic that kills susceptible bacteria by disrupting protein production. Injectable forms are mainly used for serious infections; a liposomal inhaled form has a specialised role in certain Mycobacterium avium complex lung infections.
Amiloride hydrochloride is a potassium-sparing diuretic that helps the kidneys remove sodium and excess water while reducing potassium loss. It is commonly added to another diuretic for fluid retention, heart failure, high blood pressure or ascites caused by liver cirrhosis.
A fixed combination of two diuretics. Bumetanide removes excess salt and water, while amiloride reduces potassium loss. It is used for oedema when prompt fluid removal and potassium conservation are important.
Combines two diuretics: furosemide removes excess salt and water, while amiloride limits potassium loss. It is used when prompt fluid removal is needed and conserving potassium is important.
This combination contains two diuretics. Hydrochlorothiazide increases salt and water loss through the kidneys, while amiloride reduces potassium loss. It is used for high blood pressure and fluid retention where maintaining potassium balance is important.
This combines two diuretics: furosemide removes excess salt and water, while amiloride reduces potassium loss. It is used for fluid retention when prompt diuresis and potassium conservation are important.
This combines furosemide, a loop diuretic, with amiloride, a potassium-sparing diuretic. It removes excess fluid while reducing the potassium loss furosemide can cause.
This oral gel combines lidocaine, a local anaesthetic, with aminoacridine, a local antiseptic. It is used to relieve pain from common mouth ulcers and areas irritated by dentures.
Aminophylline is a soluble form of theophylline that relaxes airway smooth muscle and stimulates breathing. This intravenous product is used in hospital for acute bronchospasm or severe reversible airway obstruction, and for certain adjunctive cardiovascular uses.
Aminophylline hydrate is a xanthine bronchodilator that provides theophylline activity. The selected injection is used in hospital to relieve bronchospasm associated with asthma or chronic obstructive pulmonary disease (COPD).
Amiodarone hydrochloride is an anti-arrhythmic that changes electrical signalling in the heart. It is usually reserved for serious fast or irregular rhythms when other treatments are unsuitable or have not worked, with specialist initiation and monitoring.
Amisulpride is an antipsychotic used to treat schizophrenia. It can help with symptoms such as hallucinations and delusions, as well as social withdrawal and reduced emotional expression.
Amitriptyline hydrochloride is a tricyclic antidepressant with pain-modifying and sedative effects. Selected products are licensed for depression, neuropathic pain, migraine and chronic tension-type headache prevention, and specialist treatment of persistent childhood bed-wetting.